Traitements2programmes
Essais1liés
Publications6liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
MSC treatmentPhase II Clinical Trial to Assess the dose-response and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (MSCs) in Severe Renal Systemic Lupus Erythematosus (SLE). Lupus Phase 2 Thérapie cellulaire Chile À vérifier
MSC treatmentPhase II Clinical Trial to Assess the dose-response and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells (MSCs) in Severe Renal Systemic Lupus Erythematosus (SLE). Lupus Phase 2 Thérapie cellulaire Chile À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
MSC treatment Lupus Phase 2 NCT03917797 Mesenchymal Stromal Cells (MSC´s) in Renal Lupus UNKNOWN

Publications

6
MoléculeIndication / populationTitreJournalDate
MSC treatment Investigation of the Efficacy of Stem Cell Therapy in a Rat Model of Cyclophosphamide-Induced Neurotoxicity. Restorative neurology and neuroscience
MSC treatment Autologous adipose-derived mesenchymal stromal cell injection for knee osteoarthritis improves pain and function without a clear increase in adverse events: A systematic review and meta-analysis of randomized controlled trials. Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
MSC treatment Efficacy and Safety of Mesenchymal Stem Cell Therapy for Alzheimer's Disease: A Systematic Review and Meta-Analysis. Stem cells and development
MSC treatment Human umbilical cord-derived mesenchymal stem cells ameliorate muscle dysfunction and metabolic dysregulation in the CuZnSOD null mouse model of sarcopenia. Experimental gerontology
MSC treatment Mesenchymal Stromal Cells Improve Postoperative Cardiac Dysmaturation in a Juvenile Porcine Model. Journal of the American Heart Association
MSC treatment Mesenchymal stem cells preserve neuronal architecture by reprogramming miRNA-mRNA regulatory networks in experimental cerebral malaria. Acta tropica